Advertisement

Topics

Abeona Therapeutics Inc.: Abeona Therapeutics Reports First Quarter 2019 Financial Results and Business Highlights

16:29 EDT 10 May 2019 | FinanzNachrichten

CMC work completed in advance of EB-101 Phase 3 VITAL trial expected to begin mid-2019 IND submitted for ABO-202 in CLN1 disease Investor conference call on Tuesday, May 14 at 10:00 a.m. ET NEW YOR...

Original Article: Abeona Therapeutics Inc.: Abeona Therapeutics Reports First Quarter 2019 Financial Results and Business Highlights

NEXT ARTICLE

More From BioPortfolio on "Abeona Therapeutics Inc.: Abeona Therapeutics Reports First Quarter 2019 Financial Results and Business Highlights"

Advertisement
Quick Search
Advertisement
Advertisement